Diabetes (TRPM7)
36717580 PDF 2023. Adipose-specific deletion of the cation channel TRPM7 inhibits TAK1 kinase-dependent inflammation and obesity in male mice.Template:36717580
36574297 PDF 2023. TRPM7 kinase is required for insulin production and compensatory islet responses during obesity.Template:36574297
34865947 PDF 2022. Associations between gene expression of magnesium transporters and glucose metabolism in pregnancy.Template:34865947
34345920 PDF 2021. TRPM7 is a crucial regulator of pancreatic endocrine development and high-fat-diet-induced beta-cell proliferation.Template:34345920
34072724 PDF 2021. The Combined Influence of Magnesium and Insulin on Central Metabolic Functions and Expression of Genes Involved in Magnesium Homeostasis of Cultured Bovine Adipocytes.Template:34072724
33891828 PDF 2021. Leptin Induces Epigenetic Regulation of Transient Receptor Potential Melastatin 7 in Rat Adrenal Pheochromocytoma Cells.Template:33891828
37837806 PDF 2023. Improvement of actin dynamics and cognitive impairment in diabetes through troxerutin-mediated downregulation of TRPM7/CaN/cofilin.Template:37837806
31697634 PDF 2019. Leptin Activates Trpm7 Channels in the Carotid Body As a Mechanism of Obesity-Related Hypertension.Template:31697634
27574117 PDF 2016. Intersection of calorie restriction and magnesium in the suppression of genome-destabilizing RNA-DNA hybrids.Template:27574117
24057349 PDF 2014. Functional TRPV and TRPM channels in human preadipocytes.Template:24057349
23765921 PDF 2014. TRPM7 channels regulate proliferation and adipogenesis in 3T3-L1 preadipocytes.Template:23765921
20875900 PDF 2010. Gene variation of the transient receptor potential cation channel, subfamily M, members 6 (TRPM6) and 7 (TRPM7), and type 2 diabetes mellitus: a case-control study.Template:20875900
19098369 PDF 2008. The role of transient receptor potential channels in metabolic syndrome.Template:19098369
30742025 PDF 2019. Diabetes-induced hypomagnesemia is not modulated by metformin treatment in mice.Template:30742025
34331987 PDF 2021. Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.Template:34331987
32393384 PDF 2020. Effect of long-term treatment of Carvacrol on glucose metabolism in Streptozotocin-induced diabetic mice.Template:32393384
31604444 PDF 2019. Hypomagnesemia is associated with new-onset diabetes mellitus following heart transplantation.Template:31604444
38186879 PDF 2024. Mechanisms and treatment of obesity-related hypertension-Part 1: Mechanisms.Template:38186879
| 36741996 PDF 2022. Effects of magnesium supplementation on improving hyperglycemia, hypercholesterolemia, and hypertension in type 2 diabetes: A pooled analysis of 24 randomized controlled trials.' |
36346820 PDF 2023. Hypomagnesemia and Cardiovascular Risk in Type 2 Diabetes.Template:36346820
35445032 PDF 2022. Dysregulated Erythroid Mg(2+) Efflux in Type 2 Diabetes.Template:35445032
34277971 PDF 2021. Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS Program.Template:34277971
33866775 PDF 2021. Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus.Template:33866775
33747462 PDF 2021. Association of dietary calcium, magnesium, and vitamin D with type 2 diabetes among US adults: National health and nutrition examination survey 2007-2014-A cross-sectional study.Template:33747462
31196609 PDF 2019. Ion channels and transporters in diabetic kidney disease.Template:31196609
28224192 PDF 2017. Serum magnesium and the risk of prediabetes: a population-based cohort study.Template:28224192
28197834 PDF 2017. Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials.Template:28197834
33716794 PDF 2021. Vascular Dysfunction in Diabetes and Obesity: Focus on TRP Channels.Template:33716794
31572181 PDF 2019. Carvacrol Attenuates Diabetic Cardiomyopathy by Modulating the PI3K/AKT/GLUT4 Pathway in Diabetic Mice.Template:31572181
30889804 PDF 2019. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling.Template:30889804
28508457 PDF 2017. Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus.Template:28508457
37441489 PDF 2023. Reduced Levels of the Antiaging Hormone Klotho are Associated With Increased Aortic Stiffness in Diabetic Kidney Disease.Template:37441489
36837924 PDF 2023. Hypomagnesemia as a Risk Factor and Accelerator for Vascular Aging in Diabetes Mellitus and Chronic Kidney Disease.Template:36837924
36185705 PDF 2022. Sodium-Glucose Cotransporter 2 Inhibitors and Management of Refractory Hypomagnesemia Without Overt Urinary Magnesium Wasting: A Report of 2 Cases.Template:36185705
35565682 PDF 2022. The Role of Magnesium in the Pathogenesis of Metabolic Disorders.Template:35565682
35277073 PDF 2022. Magnesium in Type 2 Diabetes Mellitus, Obesity, and Metabolic Syndrome.Template:35277073
34836340 PDF 2021. Effect of Dapagliflozin and Magnesium Supplementation on Renal Magnesium Handling and Magnesium Homeostasis in Metabolic Syndrome.Template:34836340
31446746 PDF 2019. Transient Receptor Potential Channels and Metabolism.Template:31446746
25733456 PDF 2015. Genetic variations in magnesium-related ion channels may affect diabetes risk among African American and Hispanic American women.Template:25733456
23343670 PDF 2013. Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a meta-analysis of 15 CHARGE Consortium Studies.Template:23343670
33499378 PDF 2021. Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes.Template:33499378
33447354 PDF 2020. Hypomagnesemia in persons with type 1 diabetes: associations with clinical parameters and oxidative stress.Template:33447354
33396318 PDF 2020. Low Dietary Magnesium and Overweight/Obesity in a Mediterranean Population: A Detrimental Synergy for the Development of Hypertension. The SUN Project.Template:33396318
30742025 PDF 2019. Diabetes-induced hypomagnesemia is not modulated by metformin treatment in mice.Template:30742025
24322525 PDF 2013. Dietary magnesium and genetic interactions in diabetes and related risk factors: a brief overview of current knowledge.Template:24322525
37908255 PDF 2023. Improvement in Serum Magnesium Levels With Sodium-Glucose Cotransporter 2 Inhibitors.Template:37908255
36684386 PDF 2023. Association of vitamin D and magnesium with insulin sensitivity and their influence on glycemic control.Template:36684386
31768494 PDF 2019. Mineral and Electrolyte Disorders With SGLT2i Therapy.Template:31768494
| 30717286 PDF 2019. Lower Plasma Magnesium, Measured by Nuclear Magnetic Resonance Spectroscopy, is Associated with Increased Risk of Developing Type 2 Diabetes Mellitus in Women: Results from a Dutch Prospective Cohort Study.' |
26265998 PDF 2015. Epigenetic profiles of pre-diabetes transitioning to type 2 diabetes and nephropathy.Template:26265998
24936262 PDF 2014. Canagliflozin-current status in the treatment of type 2 diabetes mellitus with focus on clinical trial data.Template:24936262
33716794 PDF 2021. Vascular Dysfunction in Diabetes and Obesity: Focus on TRP Channels.Template:33716794
| 30717286 PDF 2019. Lower Plasma Magnesium, Measured by Nuclear Magnetic Resonance Spectroscopy, is Associated with Increased Risk of Developing Type 2 Diabetes Mellitus in Women: Results from a Dutch Prospective Cohort Study.' |